Clinical Trial

iTBS in MCI and Mild AD

Name: iTBS in MCI and Mild AD — clinical trial record (NCT06670820)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This study aims to examine the effects of iTBS on cognitive function in individuals with MCI or mild AD, with a secondary objective of exploring prefrontal TBS mechanisms for cognitive function and the effect of iTBS on BDNF.

Trial Details

NCT Number	NCT06670820
Lead Sponsor	National Defense Medical Center, Taiwan
Conditions	Mild Cognitive Impairment (MCI), Mild Alzheimer Disease
Enrollment	80 participants
Start Date	2024-10-31
Primary Completion	2028-12-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2024-11-01